Cargando…
A network based efficient drug repurposing strategy for targeting diabesity
Autores principales: | Dutta, Subhajit, Natoli, Ted, Chanda, Deep, Rajavelu, Sindhuja, De, Debojyoti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201598/ https://www.ncbi.nlm.nih.gov/pubmed/37223537 http://dx.doi.org/10.1016/j.gendis.2022.02.015 |
Ejemplares similares
-
Insilico drug repurposing using FDA approved drugs against Membrane protein of SARS-CoV-2
por: Peele, K.Abraham, et al.
Publicado: (2021) -
Palaeolithic Diet in Diabesity and Endocrinopathies – A Vegan’s Perspective
por: Gupta, Lovely, et al.
Publicado: (2019) -
Development of a Minimal Physiologically-Based Pharmacokinetic Model to Simulate Lung Exposure in Humans Following Oral Administration of Ivermectin for COVID-19 Drug Repurposing
por: Jermain, Brian, et al.
Publicado: (2020) -
Diabesity management worldwide
por: Rajeswaran, Chinnadorai
Publicado: (2016) -
Simultaneous targeting of XPO1 and BCL2 as an effective treatment strategy for double-hit lymphoma
por: Liu, Yuanhui, et al.
Publicado: (2019)